Continuation of thiazolidinedione therapy in patients without left ventricular dysfunction who developed edema and congestive-heart-failure symptoms.
Wang
Fei
F
Veterans Affairs Medical Center, Bay Pines, FL, USA. fwang@harthosp.org
Vergara
Cunegundo
C
Carabino
Jana
J
Desilets
Alicia
A
Vasquez
Ryan
R
D000368:Aged; D000369:Aged, 80 and over; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000139:chemically induced*; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008024:Ligands; D008297:Male; D008875:Middle Aged; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D008024:Ligands; D045162:Thiazolidinediones; C089946:2,4-thiazolidinedione